Biogen Inc. buy Royal Bank of Canada
Start price
22.04.25
/
50%
€103.25
Target price
22.04.26
€195.75
Performance (%)
49.15%
Price
18:29
€154.00
Summary
This prediction is currently active. With a performance of 49.15% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 22.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.898% | -0.898% |
| iShares Core DAX® | 2.032% | 3.499% |
| iShares Nasdaq 100 | -0.145% | -1.849% |
| iShares Nikkei 225® | 4.507% | 1.976% |
| iShares S&P 500 | 0.331% | -0.103% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $221.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat